| Gene symbol | GPRC5D | Synonyms | None | Type of gene | protein-coding |
| Chromosome | 12 | Map location | 12p13.1 | dbXrefs | |
| Gene perturbation-related omics dataset | PerturbAtlas | ||||
| Description | G protein-coupled receptor class C group 5 member D | ||||
| GTO ID | GTC0938 |
| Trial ID | ChiCTR2100048888 |
| Disease | Multiple Myeloma |
| Altered gene | GPRC5D |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | GPRC5D CAR-T cells |
| Phase | Phase1|Phase2 |
| Recruitment status | Recruiting |
| Title | The clinical study of anti-GPRC5D-CAR-T in the treatment of relapsed and refractory multiple myeloma |
| Year | 2021 |
| Country | China |
| Company sponsor | The Affiliated Hospital of Xuzhou Medical University |
| Cohort 1 | |||||||
|
|||||||